Your browser doesn't support javascript.
loading
Comparative effectiveness of pegfilgrastim biosimilars vs originator for prevention of febrile neutropenia: A retrospective cohort study.
Wang, Ching-Yu; Vouri, Scott M; Park, Haesuk; Heldermon, Coy D; Brown, Joshua D.
Afiliação
  • Wang CY; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy.
  • Vouri SM; Center for Drug Evaluation and Safety, University of Florida, Gainesville.
  • Park H; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy.
  • Heldermon CD; Center for Drug Evaluation and Safety, University of Florida, Gainesville.
  • Brown JD; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy.
J Manag Care Spec Pharm ; 29(2): 119-127, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36705287
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares / Neutropenia Febril / Filgrastim / Neoplasias / Antineoplásicos Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: J Manag Care Spec Pharm Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares / Neutropenia Febril / Filgrastim / Neoplasias / Antineoplásicos Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: J Manag Care Spec Pharm Ano de publicação: 2023 Tipo de documento: Article